CDKN1A and urothelial carcinoma: Combined FIGHT-201 (n = 149) and FIGHT-207 (n = 13) data for patients with urothelial carcinoma (Supplementary Table 7) identified TSC1, which was reported in earlier analysis and CDKN1A, which was now found to be correlated nominally significantly with objective response.